Table 3.
COH cycle characteristics of patients who underwent a cycle specific vs. random start protocol and completed an oocyte retrieval
| Stimulation Measures (n=195a) | Cycle Specific (n=173) | Random Start (n=22) | P value | 
|---|---|---|---|
|  | |||
| Age | |||
| Median (Range) | 31 (15–42) | 30 (19–39) | NS | 
|  | |||
| BMI | |||
| Median (Range) | 22.96 (17.69–61.27) | 24.59 (16.20–34.40) | NS | 
|  | |||
| AMH (ng/ml) | |||
| Median (Range) | 1.70 (0–10.70) | 4.33 (0–10.39) | NS | 
|  | |||
| Peak Estradiol (pg/ml) | |||
| Median (Range) | 1445 (109–3518) | 1336 (55–4341) | NS | 
|  | |||
| Number of days of stimulation | |||
| Median (Range) | 10 (6–16) | 10 (7–15) | NS | 
|  | |||
| Total FSH Dosage | |||
| Median (Range) | 2100 (300–7500) | 1525 (750–5400) | NS | 
|  | |||
| Total HMG Dosage | |||
| Median (Range) | 825 (225–2850) | 750 (600–1800) | NS | 
|  | |||
| Total number of oocytes Retrieved | |||
| Median (Range) | 11 (0–55) | 13 (1–30) | NS | 
|  | |||
| Number of mature oocytes | |||
| Median (Range) | 8 (0–40) | 10 (1–21) | NS | 
|  | |||
| Number of oocytes cryopreserved | |||
| Median (Range) | 9 (0–37) | 12 (0–25) | NS | 
|  | |||
| Number of embryos cryopreserved | |||
| Median (Range) | 6 (0–16) | 6 (0–16) | NS | 
|  | |||
| Number of days to next cancer treatment (after PN meeting)b | n=132 | n=18 | |
| Median (Range) | 33 (16–95) | 36 (16–85) | NS | 
AMH, anti-Müllerian hormone; BMI, body mass index; COH, controlled ovarian hyperstimulation; E2, estradiol; HMG, human menotropin gonadotropin; PN, patient navigator.
n=9 started but did not complete full stimulation cycle. These patients were not included in Table 3.
n=29 did not have next treatment date available in our records; n=16 >100d until next treatment, thus not included in this analysis.